Quality of life in multiple sclerosis: Translation in French Canadian of the MSQoL-54

Health and Quality of Life Outcomes

Volumn 1, Issue , 2003, Pages

  Acquardo, Catherine ^a   Lafortune, Louise ^b   Mear, Isabelle ^a  

^a Mapi Research Institute   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COGNITION; CONTROLLED STUDY; FEMALE; FRANCE; HEALTH CARE PERSONNEL; HUMAN; LANGUAGE; MALE; MULTIPLE SCLEROSIS; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; VALIDATION PROCESS; CANADA; LINGUISTICS; METHODOLOGY; MIDDLE AGED; OCCUPATION; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; PUBLICATION; SEX DIFFERENCE; VALIDATION STUDY;

CANADA; FEMALE; HUMANS; LANGUAGE; LINGUISTICS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OCCUPATIONS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS; TRANSLATING; TRANSLATIONS;

EID: 4243090415     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-1-70     Document Type: Article

References (37)

1. Weinshenker BG: The natural history of Multiple Sclerosis. Neurol Clinic 1995, 13(1):119-146.
2. Moller A, Weidemann G, Rohde U et al.: Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Actz Psychiatr Scand 1994, 89:117-121.
3. Hauser SL: Multiple sclerosis and other demyelinating diseases. In: Harrison's principles of internal medicine Edited by: Isselbacher KJ. McGraw Hill; 1994:2281-2294.
4. Sadovnick AD, Ebers GC: Epidemiology of Multiple Sclerosis: A Critical Overview. Can J Neurol Sci 1993, 20:17-29.
5. Miltenburger C, Kobelt G: Quality of life and cost of multiple sclerosis. Clin Neurol Neurosurg 2002, 104(3):272-275.
6. Canadian Burden of Illness Study Group: Burden of Illness of Multiple Sclerosis: Part II: Quality of life. Can J Neurol Sci 1998, 25:31-38.
7. Lintern TC, Beaumont JG, Kenealy PM, Murrell RC: Quality of Life (QoL) in severely disabled multiple sclerosis patients: Comparison of three QoL measures using multidimensional scaling. Qual Life Res 2001, 10(4):371-378.
8. Kurtzke JF: Rating neurological impairment in multiple sclerosis: An expanded disability scale status (EDSS). Neurology 1983, 33:1444-1452.
9. Nortvedt MW, Riise T, Myhr KM et al.: Quality of Life in multiple sclerosis: Measuring the disease effects more broadly. Neurology 1999, 53(5):1098-1103.
10. Janardhan V, Bakshi R: Quality of Life and its relation to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol 2000, 57(10):1485-1491.
11. Pfennings LEMA, Cohen L, Van der Ploeg HM: Assessing the quality of life of patients with multiple sclerosis. In: Multiple sclerosis: Clinical challenges and controversies Edited by: Thompson AJ, Polman C, Hohlfeld R. London: Martin Dunitz; 1997:195-210.
12. Rudick RA, Sibley W, Durelli L: Treatment of multiple sclerosis with type I interferons. In: Multiple sclerosis: Advances in clinical trial design, treatment and future perspectives Edited by: Goodkin DE, Rudick RA. London: Springer; 1996:223-250.
13. Apolone G, De Carli G, Brunetti M, Garattini S: Health-related quality of life (Hr-QoL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Product-s (EMEA) recommendations on the use of Hr-QoL measures in drug approval. PharmacoEconomics 2001, 19:187-195.
14. Ritvo PG, Fischer JS, Miller DM et al.: Multiple Sclerosis Quality of life inventory: A Users Manual. New York: National Multiple Sclerosis Society 1997.
15. Rothwell PM, McDowell Z, Wong CK, Dorman PJ: Doctors and Patients don't agree: Cross-sectional study of patients and doctors perceptions and assessments of disability in Multiple Sclerosis. Br Med J 1997, 314:1580-1583.
16. Provinciali L, Ceravolo MG, Logullo F et al.: A multidimensional assessment of multiple sclerosis: Relationships between disability domains. Acta Neurol Scand 1999, 100:156-162.
17. Miller D: Health-related quality of life assessment. In Multiple Sclerosis Therapeutics Edited by: Rudick RA, Goodkin DE. London: Martin Dunitz Publishers; 1999:49-63.
18. Vickrey BG, Hays RD, Harooni R, Meyers LW: A health related quality of life measure for multiple sclerosis. Qual Life Res 1995, 4:187-206.
19. Ware JE, Sherbourne CD: A 36-item short form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
20. Ware JE, Snow KK, Kosinsky M, Gandek B: SF-36 Health Survey: Manual and interpretation guide. Boston: The Health Institute, New England Medical Center 1993:10-15.
21. Vickrey BG, Hays RD, Genovese BJ, Myers LW, Ellison GW: Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol 1997, 50(5):557-569.
22. Ford HL, Gerry E, Johnson MH, Tennant A: Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 23(12):516-521. 2001 Aug 15
23. O'Connor P, Lee L, Ng PT, Narayana P, Wolinsky JS: Determinants of overall quality of life in secondary progressive MS: A longitudinal study. Neurology 2001, 57(5):889-891.
24. Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, Baldini S, Salmaggi A, Mantia LL, Farinotti M, Caputo D, Mosconi P: Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999, 67(2):158-62.
25. Leplège A, Ecosse E, Verdier A, Perneger T: The French SF-36 Health Survey: Translation, cultural adaptation and Preliminary Psychometric Evaluation. J Clin Epidemiol 1998, 51(11):1013-1023.
26. Vernay D, Gerbaud L, Biolay S, Coste J, Debourse J, Aufauvre D, Beneton C, Colamarino R, Glanddier PY, Dordain G, Clavelou P: Qualité de vie et sclérose en plaques: validation de la version fran&aise de l'auto-questionnaire SEP-59. Rev Neurol 2000, 156(3):247-263.
27. Whorf BL: A linguistic consideration of speaking in primitive communities. In: Language, thought, and reality: Selected writings of Benjamin Lee Whorf Edited by: Carroll JB. Cambridge MA: MIT Press; 1956:65-86.
28. Mounin G: Les problèmes théoriques de la traduction. Paris: Gallimard 1963.
29. Acquadro C, Jambon B, Ellis D, Marquis P: Language and translation issues. In Quality of life and Pharmacoeconomics in clinical trials Edited by: Spilker B. Philadelphia: Lippencourt-Raven Publishers; 1996:575-585.
30. Mear I: Difficulties of international clinical trials: Cultural adaptation of quality of life questionnaires. In Health-related quality of life and Patient-reported outcomes: Scientific and useful outcome criteria Edited by: Chassany O, Caulin C. Paris: Springer Verlag Publishers; 2002:55-62.
31. Dauphinee SW, Gauthier L, Gandek B, Magnan L, Pierre U: Readying a US measure of health status, the SF-36, for use in Canada. Clin Invest Med 1997, 20(4):224-38.
32. Canadian National Population Health Survey (NPHS) 1996-2002.
33. Martel P, Vincent N, Cajolet-Laganière H: Le frana̧is québécois et la légitimité de sa description. Revue Quebecoise de Linguistique 1999, 26(2):95-106.
34. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. J Clin Epidemiol 1993, 46:1417-1432.
35. Herdman M, Fox-Rushby J, Badia X: A model of equivalence in the cultural adaptation of HRQoL instruments: The universalist approach. Qual Life Res 1998, 7:323-335.
36. Velikova G, Brown JM, Smith AB, Selby PJ: Computer-based quality-of-life questionnaires may contribute to doctor patient interactions in oncology. Br J Cancer 2002, 86:51-9.
37. Detmar SB, Aaronson NK: Quality of life assessment in daily clinical oncology practice: A feasibility study. Eur J Cancer 1998, 34:1181-6.